GlassScriptPhysician profile
Vijayendra Verma
NPI 1275585846
$31,581.57
in general payments reported to CMS, 2019-2025
54 companies · $1,810 in 2025
The $1,810 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,199 · 2020: $10K · 2021: $13K · 2022: $1,221 · 2023: $1,335 · 2024: $1,632 · 2025: $1,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,777.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20,425.34 | 2019-2025 | Farxiga, Wainua |
| Abbott Laboratories | $4,792.66 | 2019-2025 | Aveir, Diamondback Peripheral, Absolute Pro |
| Edwards Lifesciences Corporation | $620.18 | 2019-2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $506.14 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $485.14 | 2019-2025 | Lifevest |
| Medtronic, INC. | $481.43 | 2021-2025 | Symplicity G3, Onyx Frontier, Abre |
| E.R. Squibb & Sons, L.L.C. | $336.30 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $318.21 | 2019-2025 | Watchman Flx, Varithena Administration Pack |
| Abiomed | $318.06 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $281.78 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $274.59 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.64 | 2020-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $216.17 | 2019-2025 | |
| Novo Nordisk INC | $191.29 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $176.10 | 2025 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $165.03 | 2019-2025 | |
| Philips North America LLC | $149.56 | 2023 | |
| Esperion Therapeutics, INC. | $133.72 | 2020-2021 | |
| Getinge USA Sales, LLC | $125.85 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $125.80 | 2022-2024 | Optimizer, Optimizer |
| Bard Peripheral Vascular, INC. | $95.74 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $94.41 | 2019-2020 | |
| Amarin Pharma, INC. | $91.10 | 2019-2020 | |
| Cardiovascular Systems INC. | $88.51 | 2021-2023 | Diamondback Peripheral |
| Penumbra, INC. | $86.23 | 2023-2024 | Indigo System |
| Atricure, INC. | $82.95 | 2023-2024 | |
| Shockwave Medical, INC | $76.48 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $59.35 | 2023-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro |
| Merck Sharp & Dohme LLC | $56.35 | 2022-2024 | Verquvo |
| Sanofi-Aventis U.S. LLC | $55.69 | 2022 | |
| Biotronik INC. | $42.14 | 2025 | |
| Inspire Medical Systems, INC. | $37.09 | 2024 | Inspire |
| Cardinal Health 200 LLC | $33.20 | 2019 | |
| Tactile Systems Technology INC | $28.35 | 2024 | Flexitouch Plus, Entre Plus |
| Kiniksa Pharmaceuticals International, Plc | $28.21 | 2024 | Arcalyst |
| Chiesi USA, INC. | $26.66 | 2023 | Cleviprex |
| Baxter Healthcare | $25.70 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Cardiva Medical, INC. | $25.42 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $25.13 | 2021-2023 | Arcalyst |
| Biogen, INC. | $24.33 | 2025 | Skyclarys |
| Cordis US Corp. | $21.80 | 2023 | Mynxgrip |
| Stryker Corporation | $17.42 | 2025 | Flowtriever |
| Regeneron Pharmaceuticals, INC. | $16.80 | 2019 | |
| Daiichi Sankyo INC. | $15.59 | 2023 | Injectafer |
| Bridgebio Pharma, INC. | $15.50 | 2025 | Attruby |
| Actelion Pharmaceuticals US, INC. | $14.92 | 2022 | |
| Astellas Pharma US INC | $13.82 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $13.17 | 2019 | |
| Acarix USA INC. | $12.80 | 2024 | Cadscor System |
| Kowa Pharmaceuticals America, INC. | $11.72 | 2022 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijayendra Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.